Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.72
Delayed Data
As of Apr 29
 -0.05 / -2.82%
Today’s Change
1.30
Today|||52-Week Range
5.12
-9.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues12.3M9.2M9.1M7.8M
 
 
 
 
 
Cost of Goods Sold1.1M528.0K710.0K754.0K
 
 
 
 
 
Depreciation And Amortization2.5M2.6M2.5M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income8.7M6.1M5.9M4.5M
 
 
 
 
 
General Expenses30.4M33.0M31.1M29.8M
 
 
 
 
 
Research And Development22.0M24.2M22.1M20.2M
 
 
 
 
 
Total Operating Expenses34.0M36.2M34.3M33.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.7M-27.0M-25.2M-25.3M
 
 
 
 
 
Extraordinary Credit0.001.2M852.0K--
 
 
 
Extraordinary Charge-1.5M0.000.00-4.0M
 
 
 
Interest Expense On Debt1.7M1.8M1.7M1.7M
 
 
 
 
 
Other Expenses660.0K721.0K-443.0K477.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.3M-26.8M-26.4M-30.5M
 
 
 
 
 
Net Income-24.3M-26.8M-26.4M-30.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS235.7M242.1M242.3M242.6M
 
 
 
 
 
Shares To Calculate EPS Diluted235.7M242.1M242.3M242.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.11-$0.11-$0.13
 
 
 
 
 
EPS Diluted-$0.10-$0.11-$0.11-$0.13